{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T02:03:56Z","timestamp":1778724236928,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.vaccine.2008.04.084","type":"journal-article","created":{"date-parts":[[2008,5,23]],"date-time":"2008-05-23T08:41:40Z","timestamp":1211532100000},"page":"3922-3931","source":"Crossref","is-referenced-by-count":12,"title":["Kinetics of cell migration to the dermis and hypodermis in dogs vaccinated with antigenic compounds of Leishmania braziliensis plus saponin"],"prefix":"10.1016","volume":"26","author":[{"given":"Juliana","family":"Vitoriano-Souza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre B.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00e1dia D.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolfo C.","family":"Giunchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Correa-Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udia M.","family":"Carneiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.04.084_bib1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2008.04.084_bib2","first-page":"75","article-title":"Leishmaniose visceral urbana (no c\u00e3o e no homem) em Sobral, Cear\u00e1","volume":"47","author":"Deane","year":"1955","journal-title":"Hospital"},{"key":"10.1016\/j.vaccine.2008.04.084_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vetimm.2004.08.010","article-title":"Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis","volume":"103","author":"Chamizo","year":"2005","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2008.04.084_bib4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.rvsc.2005.09.011","article-title":"Parasite density and impaired biochemical\/hematological status are associated with severe clinical aspects of canine visceral leishmaniasis","volume":"81","author":"Reis","year":"2006","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2008.04.084_bib5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.vetimm.2006.02.001","article-title":"Isotype patterns of immunoglobulins: hall-marks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi","volume":"112","author":"Reis","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2008.04.084_bib6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2249.2006.03206.x","article-title":"Phenotypic features of circulating leucocytes as immunological markers for clinical status and bone marrow parasite density in dogs naturally infected by Leishmania chagasi","volume":"146","author":"Reis","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2008.04.084_bib7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jcpa.2006.06.005","article-title":"Relationship between canine visceral leishmaniosis and the Leishmania (Leishmania) chagasi burden in dermal inflammatory foci","volume":"135","author":"Giunchetti","year":"2006","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.vaccine.2008.04.084_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.vetimm.2006.10.001","article-title":"Analysis of the cytokine profile in spleen cells from dogs naturally infected by Leishmania chagasi","volume":"115","author":"Lage","year":"2007","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2008.04.084_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0304-4017(02)00115-2","article-title":"Chemotherapy of canine leishmaniosis","volume":"106","author":"Baneth","year":"2002","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2008.04.084_bib10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-3164.2005.00460.x","article-title":"Treatment of canine Old World visceral leishmaniasis: a systematic review","volume":"16","author":"Noli","year":"2005","journal-title":"Vet Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2008.04.084_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/00034983.1995.11813015","article-title":"Experimental models for leishmaniasis and for testing anti-leishmanial vaccines","volume":"89","author":"Hommel","year":"1995","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.vaccine.2008.04.084_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-4017(01)00486-1","article-title":"An update on anti-leishmanial vaccine candidates and prospects for a canine Leishmania vaccine","volume":"100","author":"Gradoni","year":"2001","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2008.04.084_bib13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/1568008023340631","article-title":"Vaccination against Leishmania infections","volume":"2","author":"Mauel","year":"2002","journal-title":"Curr Drug Targets Immune Endocr Metabol Disord"},{"key":"10.1016\/j.vaccine.2008.04.084_bib14","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0264-410X(00)00339-X","article-title":"A phase III trial of efficacy of the FML-vaccine against canine Kala-azar in an endemic area of Brazil (S\u00e3o Gon\u00e7alo do Amaranto, RN)","volume":"19","author":"Da Silva","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.084_bib15","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.vaccine.2003.11.039","article-title":"Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine","volume":"22","author":"Borja-Cabrera","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.084_bib16","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.vaccine.2004.11.061","article-title":"Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes","volume":"23","author":"Lemesre","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.084_bib17","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1016\/j.vaccine.2007.02.083","article-title":"Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial","volume":"25","author":"Lemesre","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.084_bib18","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1590\/S0074-02761996000600006","article-title":"Phases I and II open clinical trials of a vaccine against Leishmania chagasi infections in dogs","volume":"91","author":"Mayrink","year":"1996","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2008.04.084_bib19","first-page":"441","article-title":"Immune responses in vaccinated dogs with autoclaved Leishmania major promastigotes","volume":"30","author":"Lasri","year":"1999","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2008.04.084_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0147-9571(00)00026-6","article-title":"Nitric oxide production by macrophages of dogs vaccinated with killed Leishmania infantum promastigotes","volume":"24","author":"Panaro","year":"2001","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2008.04.084_bib21","doi-asserted-by":"crossref","first-page":"7674","DOI":"10.1016\/j.vaccine.2007.08.009","article-title":"Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs","volume":"25","author":"Giunchetti","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.084_bib22","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.vaccine.2007.11.057","article-title":"A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs","volume":"26","author":"Giunchetti","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.084_bib23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.rvsc.2007.09.008","article-title":"Antigenicity of a whole parasite vaccine as promising candidate against canine leishmaniasis","volume":"85","author":"Giunchetti","year":"2008","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2008.04.084_bib24","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0140-6736(86)91725-3","article-title":"Leishmania donovani: an opportunistic infection associated with progressive disease in three immunocompromised patients","volume":"8482","author":"Badar\u00f3","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.04.084_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00002030-199102000-00011","article-title":"Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of literature","volume":"5","author":"Altes","year":"1991","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2008.04.084_bib26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0035-9203(93)90441-R","article-title":"HIV-Leishmania co-infections in Italy: serological data as an indication of the sequence of acquisition of two infections","volume":"87","author":"Gradoni","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.04.084_bib27","series-title":"Magnitude of the problem","author":"World Heath Organization","year":"2008"},{"key":"10.1016\/j.vaccine.2008.04.084_bib28","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0738-081X(96)00040-5","article-title":"Vaccine for prophylaxis and immunotherapy, Brazil","volume":"14","author":"Genaro","year":"1996","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.vaccine.2008.04.084_bib29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00928181","article-title":"A new approach to phylogeny of Leishmania: species-specificity of glycoconjugate ligands for promastigote internalization into murine macrophages","volume":"76","author":"Palatnik de Sousa","year":"1990","journal-title":"Parasitol Res"},{"key":"10.1016\/j.vaccine.2008.04.084_bib30","first-page":"290","article-title":"The FML vaccine (fucose-mannose ligand) protects hamsters from experimental Kala-azar","volume":"46","author":"Palatnik de Sousa","year":"1994","journal-title":"Cienc Cult (J Braz Assoc Adv Sci)"},{"key":"10.1016\/j.vaccine.2008.04.084_bib31","first-page":"547","article-title":"Experimental murine Leishmania donovani infection immunoprotection by fucose mannose ligand (FML)","volume":"27","author":"Palatnik de Sousa","year":"1994","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.vaccine.2008.04.084_bib32","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/S0264-410X(02)00294-3","article-title":"Long lasting protection against canine Kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S\u00e3o Gonzalo do Amarante, RN)","volume":"20","author":"Borja-Cabrera","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.084_bib33","doi-asserted-by":"crossref","first-page":"8346","DOI":"10.4049\/jimmunol.175.12.8346","article-title":"Saliva from Lutzomyia longipalpis induces CC chemokine ligand 2\/monocyte chemoattractant protein-1 expression and macrophage recruitment","volume":"175","author":"Teixeira","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.04.084_bib34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0046-8177(76)80036-6","article-title":"Cell mediated immunity and the inflammatory system","volume":"7","author":"Cohen","year":"1976","journal-title":"Hum Pathol"},{"key":"10.1016\/j.vaccine.2008.04.084_bib35","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/BF01972801","article-title":"Acute and chronic inflammatory responses to local administration of recombinant IL-1 alpha, IL-beta, TNF alpha, IL-2 and IFN gamma in mice","volume":"27","author":"Dunn","year":"1989","journal-title":"Agents Actions"},{"key":"10.1016\/j.vaccine.2008.04.084_bib36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.182.1.99","article-title":"Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses","volume":"182","author":"Berg","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2008.04.084_bib37","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1445-2197.1984.tb05447.x","article-title":"Peritoneal neutrophilia: a potential indicator of the surgical acute abdomen","volume":"54","author":"Stewart","year":"1984","journal-title":"Aust NZ J Surg"},{"key":"10.1016\/j.vaccine.2008.04.084_bib38","unstructured":"De Souza, RCA. Estudo da cin\u00e9tica celular da resposta inflamat\u00f3ria causada pela crioterapia experimental em pele normal de camundongos utilizando o m\u00e9todo de bolsas de ar no subcut\u00e2neo. MSc dissertation. Florian\u00f3polis: Universidade Federal de Santa Catarina; 2001."},{"key":"10.1016\/j.vaccine.2008.04.084_bib39","series-title":"Imunologia","first-page":"11","article-title":"Imunidade natural e inflama\u00e7\u00e3o","author":"Jancar","year":"2001"},{"key":"10.1016\/j.vaccine.2008.04.084_bib40","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.vaccine.2006.11.057","article-title":"Safety trial using the Leishmune vaccine against canine visceral leishmaniasis in Brazil","volume":"25","author":"Parra","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.084_bib41","first-page":"1","article-title":"Saponins as vaccine adjuvants","volume":"13","author":"Kensil","year":"1996","journal-title":"Crit Rev Ther Drug"},{"issue":"1","key":"10.1016\/j.vaccine.2008.04.084_bib42","first-page":"107","article-title":"Adjuvant effect of Quil A in porcine humoral immune response","volume":"129","author":"Houdayer","year":"1978","journal-title":"Ann Immunol Cell Biol (Institute Pauster)"},{"key":"10.1016\/j.vaccine.2008.04.084_bib43","first-page":"369","article-title":"Protective effects of Panax ginseng on muscle injury and inflammation after eccentric exercise","volume":"130","author":"De Oliveira","year":"2001","journal-title":"Comp Biochem"},{"key":"10.1016\/j.vaccine.2008.04.084_bib44","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.tim.2006.11.009","article-title":"Neutrophils and intracellular pathogens: beyond phagocytosis and killing","volume":"15","author":"Appelberg","year":"2007","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2008.04.084_bib45","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1182\/blood-2006-12-063826","article-title":"Neutrophils efficiently cross-prime naive T cells in vivo","volume":"110","author":"Beauvillain","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2008.04.084_bib46","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1034\/j.1600-065X.2000.17706.x","article-title":"The neutrophil as a cellular source of chemokines","volume":"177","author":"Scapini","year":"2000","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2008.04.084_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0625.2000.009001001.x","article-title":"Role of neutrophils in induction of acute inflammation in T-cell-mediated immune dermatosis, psoriasis: a neutrophil-associated inflammation-boosting loop","volume":"9","author":"Terui","year":"2000","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.vaccine.2008.04.084_bib48","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.coi.2006.03.010","article-title":"The role of CD8 T cells in innate immune and in antigen non-specific protection","volume":"18","author":"Berg","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2008.04.084_bib49","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1590\/S0074-02762007005000069","article-title":"T-cell responses associated with resistance to leishmania infection in individuals from endemic areas for Leishmania (Viannia) braziliensis","volume":"102","author":"Bittar","year":"2007","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2008.04.084_bib50","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0092-8674(94)90266-6","article-title":"Nitric oxide synthases: roles, tolls, and controls","volume":"78","author":"Nathan","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2008.04.084_bib51","doi-asserted-by":"crossref","first-page":"13725","DOI":"10.1016\/S0021-9258(17)36703-0","article-title":"Regulation of biosynthesis of nitric oxide","volume":"269","author":"Nathan","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2008.04.084_bib52","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.4049\/jimmunol.155.7.3501","article-title":"Sandfly vector saliva selectively modulates macrophage functions that inhibit killing of L. major and nitric oxide production","volume":"155","author":"Hall","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.04.084_bib53","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/ni1001-907","article-title":"Nitric oxide and the immune response","volume":"2","author":"Bogdan","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2008.04.084_bib54","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1098\/rstb.1997.0115","article-title":"Cytokines and nitric oxide as effector molecules against parasitic infections","volume":"352","author":"Liew","year":"1997","journal-title":"Philos Trans Roy Soc B"},{"key":"10.1016\/j.vaccine.2008.04.084_bib55","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0065-308X(08)60208-0","article-title":"Immunology of leishmaniasis","volume":"32","author":"Liew","year":"1993","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.vaccine.2008.04.084_bib56","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4049\/jimmunol.151.1.301","article-title":"Traces of bacterial lipopolysaccharide suppress IFN-gamma-induced nitric oxide synthase gene expression in primary mouse macrophages","volume":"151","author":"Bogdan","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.04.084_bib57","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/eji.1830270409","article-title":"Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation","volume":"27","author":"Vouldoukis","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2008.04.084_bib58","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/S1567-5769(01)00091-1","article-title":"The role of NO in contact hypersensitivity","volume":"1","author":"Ross","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2008.04.084_bib59","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2567.2006.02394.x","article-title":"The regression of a canine Langerhans cell tumour is associated with increased expression of IL-2, TNF-alpha, IFN-gamma and iNOS mRNA","volume":"118","author":"Kaim","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2008.04.084_bib60","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0264-410X(02)00449-8","article-title":"The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI)","volume":"13","author":"Bonhoeffer","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.084_bib61","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.vaccine.2003.09.005","article-title":"Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation","volume":"22","author":"Rothstein","year":"2004","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08005537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08005537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T16:17:13Z","timestamp":1708964233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08005537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":61,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0264410X08005537"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.04.084","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}